Literature DB >> 31978180

Dispensing of antibiotics without prescription and associated factors in drug retail outlets of Eritrea: A simulated client method.

Merhawi Bahta1, Sirak Tesfamariam2, Dawit G Weldemariam3, Hermella Yemane4, Eyasu H Tesfamariam5, Tesfamariam Alem1, Mulugeta Russom6.   

Abstract

Dispensing antibiotics without prescription is irrational and can hasten the emergence and spread of antibiotic resistance. This study aims at determining the extent of this practice and its determinants in all drug retail outlets of Eritrea. A cross-sectional simulated client method was used to conduct the study. Data was collected between July and August 2019, entered and analyzed using Statistical Package for Social Science version 22. Descriptive analysis was performed using mean (standard deviation), median (interquartile range), frequency, percentage, as appropriate, for independent variables. Logistic regression, at bivariate and multivariate levels, along with odds ratio (95% confidence interval) was used to determine the association between the dispensing of antibiotics without prescription and independent variables. P-values less than 0.05 were considered as statistically significant. The extent of dispensing antibiotics without prescription was found to be 87.6% with the most frequently dispensed antibiotics being ciprofloxacin (47.8%) and co-trimoxazole (37.5%). Furthermore, 12.4% of the drug retail outlet attendants did not dispense antibiotics because they preferred a referral to health facilities (52.6%), were following administrative restrictions not to sell antibiotics (42.1%), or did not have the necessary antibiotics (31.6%). Private community pharmacies (AOR = 7.68, 95% CI: 1.67, 35.37; p = 0.009) and private drug shops (AOR = 10.65, 95% CI: 1.96, 57.93; p = 0.006) were more likely to dispense antibiotics compared to the governmental community pharmacies. Dispensing antibiotics without prescription was more likely to occur in the Maekel (central) region (AOR = 3.76, 95% CI: 1.19, 11.92; p = 0.024) compared to the remaining regions combined. In conclusion, the sales of antibiotics without prescription in the drug retail outlets of Eritrea is alarming which requires immediate attention from policymakers.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31978180      PMCID: PMC6980490          DOI: 10.1371/journal.pone.0228013

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Antibiotic resistance is a global public health threat that warrants immediate global intervention [1, 2]. To tackle this problem, the WHO, in its 68th world health assembly, passed a resolution, based on the global action plan, that instructs all member states to develop a national strategic plan on combating antimicrobial resistance [3]. One of the strategic objectives of the global action plan is to optimize the rational use of antimicrobials. In line with the WHO resolution, Eritrea developed a national action plan to combat antimicrobial resistance. Moreover, the National Medicines and Food Administration in collaboration with stakeholders developed medicines schedule guide in June 2019. The medicines are scheduled by the need for prescription and their availability in drug retail outlets. On top of the above initiatives, Eritrea has been conducting annual campaigns on awareness of antibiotic resistance using a one-health approach since 2017. Self-medication and antibiotics dispensing without prescription in drug retail outlets [4-7] are irrational practices that can accelerate the emergence and spread of antibiotic resistance [8]. It has been estimated that more than 50% of antibiotics worldwide are sold without prescription [9]. Although dispensing antibiotics without prescription in the developed world is minimal [10-14], the problem is much higher in Africa and other low-income countries due to poor healthcare regulations [12]. In Eritrea, to the best of the authors’ knowledge, the prevalence of dispensing antibiotics without prescription is not known. However, a recent study conducted in Asmara, the capital city of Eritrea, reported a significant rate (45.1%) of self-medication with antibiotics [15]. In most countries, as antibiotics are accessed mostly through community pharmacies, intervening at the practice of these drug retail outlets can minimize inappropriate use of antibiotics including self-medication and sales without prescription [16-18]. This study, therefore, was conducted to determine the extent of dispensing antibiotics without prescription and its associated factors in Eritrea. The results will be helpful to programmers, policymakers, regulators and other concerned bodies to know the burden of the problem and identify areas of intervention.

Materials and methods

Study design and setting

A cross-sectional investigational study using simulated client method was conducted between July and August 2019 in all but four drug retail outlets available in Eritrea. Totally, 75 private and 13 governmental drug retail outlets (49 pharmacies and 39 drug shops) are located in all six administrative regions of Eritrea. The four drug retail outlets were excluded either due to budget constraints, as two of them were located in hard-to-reach areas, or conflict of interest.

Study population

In Eritrea, the professional in charge of a pharmacy is a pharmacist, while those in charge of drug shops are either a pharmacist or pharmacy technician. This study included 84 pharmacies and drug shops which were open to the public during the study period. The dispensers of these drug retail outlets during the visit were considered as the study population.

Data collection tool and approach

To capture the routine performance of dispensing, dispensers were blinded using simulated clients to collect data. Simulated client method is an effective method of deriving valid measures of healthcare providers’ actual practices, which are challenging to achieve through any other method [19, 20]. Data was collected by six simulated clients (three female and three male final year pharmacy students), not identifiable by the dispensers. To ensure uniform presentation and consistency on their level of demand (data collection), the simulated clients were well-trained and rehearsed the role plays for two days. Prior to the data collection, the simulated clients were asked to fill a non-disclosure confidentiality form to conduct the study in strict confidence and avoid disclosure of any malpractice of the dispensers to other parties. The clients simulated the same case with the same signs and symptoms and provided consistent answers for queries raised by the dispensers. Female simulated clients were acting as patients with a case of uncomplicated urinary tract infection (UTI) presenting with a chief complaint of “burning sensation upon urination for 3 consecutive days.” If further asked by the dispenser, other aspects of the medical history included the presence of dysuria, frequency of urination, urgency, supra-pubic pain, and sensation of bladder fullness or lower abdominal discomfort with the absence of fever, chills, vaginal discharge, flank pain, allergies, and pregnancy. On the other hand, the male simulated clients acted as patients with acute watery diarrhea experiencing “loose bowel motion accompanied by diarrhea for 3 days”. Further medical history on request included the presence of watery stool, loss of appetite, generalized body weakness, slightly increased bowel sounds, and a four times frequency of bowel movement per day with absence of blood/pus in the stool, vomiting, fever, abdominal tenderness, and allergies. These two clinical cases were selected since they are common ailments in the general population, antibiotics may not be warranted in all patients with those symptoms, and if needed, laboratory aided diagnosis is required for confirmation of the etiologic pathogen before antibiotic prescription. Each drug retail outlet was visited twice (one for each case) with a reasonable time gap between the visits in order to avoid suspicion from dispensers. The simulated clients were accompanied by another colleague to minimize recall bias and improve the reliability of the information provided during the encounter. Three gradually incremental levels of demand were used to convince the drug retail outlet attendants to get an antibiotic without prescription. The details of the visit process are depicted in Fig 1.
Fig 1

Data collection process.

key indicators* included name tag, professional license, the appearance of the dispenser key indicators of dispensing practices ** included the name of antibiotics dispensed (if any), demand level, reasons for not dispensing, and alternative medications offered (if any) NMFA: National Medicines and Food Administration.

Data collection process.

key indicators* included name tag, professional license, the appearance of the dispenser key indicators of dispensing practices ** included the name of antibiotics dispensed (if any), demand level, reasons for not dispensing, and alternative medications offered (if any) NMFA: National Medicines and Food Administration. The data recording form (S1 File) comprises three sections including questions on demographic information of both the drug retail outlets and dispensers, the response of the dispenser to the request of the simulated clients, and comments, such as the appearance of the dispenser to help with the identification, that couldn’t be filled in the other sections. Two days prior to the actual study, a pre-test for the questionnaire was conducted in four drug retail outlets of Asmara. The data gathered from these sites were included in the analysis since no change was made on the data recording form and data collection approach. For each visited pharmacy, the database of the Licensing office, National Medicines and Food Administration was used to retrieve information that includes the exact age, profession and work experience of a dispenser.

Ethical consideration

Ethical clearance to conduct the study was obtained from the National Medicines and Food Administration of the Ministry of Health, the authority to grant permission for such investigational studies. All ethical and professional considerations were followed throughout the study to keep the data strictly confidential. The names of the drug retail outlets and identifiers of the dispenser are kept confidential. Investigational information will only be disclosed at the aggregate level and all findings at a personal level will be kept confidential.

Statistical analysis

Data was entered and analyzed using the Statistical Package for Social Science version 22 (SPSS-22). Both descriptive and analytical analysis were carried out. Descriptive analysis was performed using mean (SD) or median (IQR) as appropriate for continuous variables. Categorical variables were summarized using frequency and percentage. The association between the dispensing of antibiotics without prescription and variables (type and location of the drug retail outlet, age, sex, work experience and profession of the dispenser, and type of clinical scenario) was explored using bivariate and multivariate logistic regression. Variables that were found to be significant at bivariate level were included at the multivariate level. Odds ratio with 95% confidence interval was calculated for both bivariate and multivariate associations. P-values less than 0.05 were considered as significant throughout the study.

Results

A total of 153, out of the expected 168 questionnaires, were fully completed with a response rate of 91.1%. The majority of dispensers studied (64.1%) were males. The study population comprised 41.8% pharmacy technicians, 35.9% pharmacists and others (Table 1). The mean age of the dispensers was found to be 48.6 years (SD = 14) with a median dispensing experience of 10 years (IQR = 14).
Table 1

Socio-demographic characteristics of the dispensers.

VariablesFrequencyPercent
Sex
Male9864.1
Female5535.9
Title of the dispenser
Pharmacist5535.9
Pharmacy technician6441.8
Nursing degree21.3
Nursing diploma53.3
Health assistant1711.1
Nurse aid10.7
Non professional95.9

Age (Mean = 48.6, SD = 14, Range = 24 to 83)

Work experience (Median = 10, IQR = 14, Range = 0 to 47)

Age (Mean = 48.6, SD = 14, Range = 24 to 83) Work experience (Median = 10, IQR = 14, Range = 0 to 47) The extent of dispensing antibiotics without prescription was found to be 87.6%. Specifically, for uncomplicated UTI and acute watery diarrhea, antibiotics were dispensed in 89.2% and 86.1% of the cases respectively. The frequently dispensed antibiotics were ciprofloxacin (47.8%) and co-trimoxazole (37.5%) (Table 2). For individual cases, co-trimoxazole (53.6%) in acute watery diarrhea and ciprofloxacin (56.7%) in uncomplicated UTI were the most dispensed. Moreover, 81.3% of the dispensed antibiotics were given at demand level one, 11.2% at demand level two, and 6.7% at demand level three.
Table 2

Percentage of the antibiotics dispensed without prescription.

Antibiotics dispensedAcute Watery DiarrheaAcute Uncomplicated UTITotal
FrequencyPercentFrequencyPercentFrequencyPercent
Ciprofloxacin2739.13856.76547.8
Co-trimoxazole3753.61420.95137.5
Amoxicillin001116.4118.1
Doxycycline22.934.553.7
Tinidazole22.911.532.2
Metronidazole11.40010.7
Total6910067100136100
In 12.4% of the simulated encounters, antibiotics were not dispensed without prescription. In 52.6% of these encounters, the dispenser chose to refer the patient for further clinical investigation instead of dispensing antibiotics without prescription. Other reasons for not dispensing were administrative restrictions (rules and regulations set by individual drug retail outlets for their own practices) not to sell antibiotics without prescriptions (42.1%) and unavailability of antibiotics during the visit (31.6%). However, other than antibiotics, loperamide and oral rehydration salts were provided to a few clients. Chi-square test was done to see if there is any association between antibiotics dispensed without prescription and the independent categorical variables namely sex and profession of the dispenser, type of the drug retail outlet (private community pharmacy, private drug shop, or governmental community pharmacy), regional location of the drug retail outlet, and type of clinical scenario. Among the tested variables; regional location of the drug retail outlet (p = 0.008) and type of the drug retail outlet (p<0.0001) were found to be significantly associated with dispensing antibiotics without prescription. A binary logistic regression was performed to observe the magnitude of the influence and to test continuous variables (age and work experience). In the bivariate analysis, type of the drug retail outlet (p<0.0001), regional location (p = 0.012), and age of the dispenser (p = 0.019) were found to significantly influence the dispensing of antibiotics without prescription. Even though the association with work experience was found to be insignificant (p = 0.185), the factor of experience was included in the multivariate level as it might have an effect on the other variables (Table 3).
Table 3

Bivariate and multivariate analysis on the association of independent variables and dispensing antibiotic without prescription.

VariablesBivariate analysisMultivariate analysis
COR95% CIp-valueAOR95% CIp-value
Type of drug outlet
Private community pharmacy (n = 62)11.15(3.02, 41.18)<0.00017.68(1.67, 35.37)0.009
Private drug shop (n = 68)9.69(2.84, 33.11)<0.000110.65(1.96, 57.93)0.006
Governmental community pharmacy (n = 23)RefRef
Location of drug outlet
Maekel region (n = 98)3.63(1.33, 9.86)0.0123.76(1.19, 11.92)0.024
Other regions (n = 55)RefRef
Age of the dispenser1.05(1.01, 1.09)0.0191.000(0.94, 1.06)0.933
Year of experience1.04(0.98, 1.09)0.1851.025(0.96, 1.10)0.494
To adjust for confounding variables, multivariate analysis was performed for variables that were found to be significant at bivariate level. The result shows that the type of drug outlet and regional location retained their significance. It was found that private community pharmacies (AOR = 7.68, 95% CI: 1.67, 35.37) and private drug shops (AOR = 10.65, 95% CI: 1.96, 57.93) were more likely to dispense antibiotics without prescription compared to the governmental community pharmacies. Regarding the location of the drug retail outlets, those located in Maekel (central) region, which include facilities in the capital city, had a higher inclination of dispensing antibiotics without prescription (AOR = 3.76, 95%CI: 1.19, 11.92) compared to the remaining outlets in the other five regions combined (Table 3).

Discussion

Dispensing antibiotics without prescription in drug retail outlets available in Eritrea was found to be commonly practiced. The result of this study reveals easy access to antibiotics which can, in turn, accelerate the development of antibiotics resistance [21]. Furthermore, this can result in wastage of resources, wrong choice of antibiotics, and experience of adverse drug reactions. Dispensing of antibiotics without prescription was found to be less frequent in studies conducted in Gipuzkoa, a Spanish province (17.5%) [11], Republic of Srpska (18.5%) [22], north-western Spain (18.83%) [23], Beirut and its suburbs, Lebanon (32%) [24], Sri Lanka (41%) [25], Catalonia, Spain (45.2%) [26], and urban cities of China (66.8%) [10]. A result extracted from a study done in Albania (80%) [14] was comparatively consistent with findings of the current study, but higher results were observed in studies done in Moshi municipality, Tanzania (92.3%) [12], Mizan-Aman town, southwest Ethiopia (94.4%) [27], and in Lusaka district, Zambia (100%) [13]. The discrepancy in the magnitude observed might be due to differences in the simulated cases, the methodological approach used, and sample size. These findings together with our study’s result; however, reveals frequent misuse of antibiotics in drug retail outlets across broad regions of the world, especially in Africa. Even though the root causes may be accurately identified by a qualitative study, weak regulation of antibiotic sales, lax enforcement of existing policies on antibiotics dispensary, and unavailability of medicines scheduling could be the main causes of pervasive non-prescription access to antibiotics. Most of the antibiotics were dispensed at demand level one, which reflects the current study’s dispensers’ leniency towards the sales of medicines in general, and antibiotics in particular. A similar case was observed in a study done in Ethiopia, where most antibiotics were dispensed when the simulator asked for any medication to alleviate his/her symptoms [27]. Inadequate training targeted towards authorized dispensers about rational use of antibiotics and high patient demand of seeking medications to avoid lengthy time in health facilities due to over-stretched healthcare systems in developing countries [28] may have contributed to the willingness of the dispensers to give antibiotics. Continuing professional development and on-job training of drug dispensers should be routinely emphasized to mitigate these problems. In the present study, governmental community pharmacies were found to be less inclined to dispense antibiotics and administrative restriction was the main reason reported for not dispensing antibiotics without prescription. Additionally, several business licenses of drug retail outlets in Eritrea are owned by non-professionals, thus owners might put pressure on the licensed pharmacy professionals for the sake of economic benefits and this may compromise the decision of the professionals. The difference in dispensing antibiotics without prescription was influenced by the location of the drug retail outlets, which was higher in Maekel region compared to the other regions combined. Unavailability of antibiotics during the study period was the main reason that dispensers in the other region claimed for not dispensing antibiotics. The “other regions combined” have a wide difference in their location, and hence the difference in the dispensing behavior could be due to unexplored factors. No difference in the dispensing antibiotics without prescription was observed according to the profession of the dispensers. Even though the distribution shows high involvement of unauthorized dispensers including non-healthcare professionals, the authorized dispensers; pharmacists and pharmacy technicians, did not appear to impact appropriate practice. Ciprofloxacin was the most frequently dispensed antibiotic, especially in uncomplicated UTI similar to findings from an Ethiopian [27] and a Sri Lankan [25] studies. Ciprofloxacin is in the watch group of WHO antibiotics category [21] and being from the fluoroquinolone class, cross-resistance to other fluoroquinolone drugs is challenging, especially for those used in the second-line anti-TB treatment [29]. This shows that pharmacists’ role in combating antibiotic resistance was not appreciable, and warrants continuous education, sensitization, and strengthening the regulation on the rational use of antibiotics.

Limitation of the study

The case scenarios selected for the study could have influenced the extent of the dispensing antibiotics practice. Simulating other cases like upper respiratory tract infections (acute otitis media, rhinosinusitis, acute pharyngitis), lower respiratory tract infections, or tonsillitis might have given a different picture of the practice.

Conclusion and recommendations

Sales of antibiotics without prescription in Eritrean drug retail outlets is alarming which can escalate the issue of antibiotic resistance and compromise the availability of antibiotics in the country. Strengthening existing laws, guidelines and national medicines regulatory capacity, continuous awareness-raising programs, and implementation of medicines scheduling are recommended to achieve more prudent use of antibiotics. Besides, future regulatory interventions should consider the access and excess use of antibiotics. Further qualitative study is also suggested to unveil reasons that motivate the sale of antibiotics without prescription.

Data recording form.

(PDF) Click here for additional data file. 20 Nov 2019 PONE-D-19-28324 Prevalence of antibiotic dispensing without prescription and associated factors in drug retail outlets of Eritrea: a simulated client method PLOS ONE Dear Dr. Weldemariam Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please address each of the comments raised below by the reviewer.  In addition, I would ask you to respond to the following concerns: 1. Line 93 - it appears that you surveyed ALL pharmacies and drug shops in Eritrea.  Please clarify 2. Lines 195 - 200 - please expand this.  Zonal location and type of pharmacy were associated with dispensing, but it is not clear what that means.  What is a zonal location?  Which ones had which effect?  What kind of pharmacy was associated with dispensing? 3. Lines 223-238 - This entire paragraph is confusing.  It seems to say that the likelihood of dispensing without a prescription is lower in some areas and higher in others.  Referring to this as prevalence is confusing. 4.  The paper needs a Limitations section.  What should the reader be aware of when determining the validity and accuracy of the paper? 5. References - Reference 13 has no journal listed.  References 16 and 20 have extraneous information in the citation. 6.  You correctly point out that uncontrolled access to antibiotics has a number of significant concerns including increases bacterial resistance.  But it is also important to consider that strictly enforcing restrictions on drug sales in many parts of the Global South can have the unintended consequence of preventing patients who cannot afford a clinic or doctor from receiving any treatment at all.  What policy recommendations do you make as a result of your study? We would appreciate receiving your revised manuscript by December 6, 2019. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, John Rovers, PharmD, MIPH Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please ensure you have thoroughly discussed any potential limitations of this study within the Discussion section. 3. During your revisions, please note that a simple title correction is required to "Prevalence of antibiotic dispensing without prescription and associated factors in drug retail outlets of Eritrea: a simulated client method" due to a missing space in the current title. Please ensure this is updated in the manuscript file and the online submission information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear Authors, I very much enjoyed reading your paper. Thank you for allowing me to review it. I have the following comments: 1) Around line 122- I think it’s important that you note that both of these disease states likely require laboratory aided diagnosis to confirm if it is a bacterial infection; make that connection so that the reader (especially if they are not a healthcare professional) understands that antibiotics may not be warranted in all patients with these symptoms. This is key as otherwise the reader may not connect the irrational use piece and would need to understand why the patient would need to go to the doctor for a workup vs just receiving the antibiotic. 2) Figure 1 - will the lines 131-136 go with the figure? Otherwise it is confusing. 3) Line 142: I believe you mean it was a “pilot test” of the data collection process/questionnaire vs a “pre-test” which would imply that there is a post-test 4) Line 192 and again lower, I’m confused about the term “administrative restrictions” operationalize this term in the paper 5) I would like to see the sample size for each of the types of pharmacies and pharmacy locations. Consider adding n= to each on Table 3 6) Line 224 – your study doesn’t prove if there is “excessive consumption” as your student doesn’t specifically measure if those with the symptoms may have an infection. I would add the word “potential” excessive consumption – or something similar 7) Line 239 – this is an assumption, change “can” to “may” or “might” 8) Line 269 – while you mention Cipro is on the WHO watch group, I think it is important to address the potential issues with TB and prescribing a drug from this class without consideration of TB. 9) As PLOS does not have a copyeditor, I would have someone who is skilled and is not one of the authors (for fresh eyes), give your paper a final proofreading. There are some issues with spacing - sometimes too many, sometimes not enough. On occasion there are dropped articles ("a"); that said, the articles could be a matter of British vs. American English. There are also some capitalization inconsistencies in table 1, and in your paper pharmacy should always be lowercase unless part of the name of a location. Eliminate the conjunction in line 140. Overall, this is a well done study and well written paper. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. 18 Dec 2019 Response to reviewers We would like to thank the academic editor and reviewer for their thorough review and constructive comments. After carefully considering the points raised, we have made the following changes to the manuscript and put forward explanations as required. Academic editor’s comments 1. Line 93 - it appears that you surveyed ALL pharmacies and drug shops in Eritrea. Please clarify Response: Comment accepted. The survey was done in 84 pharmacies and drug shops (out of total 88), in which the four were excluded for several reasons. Accordingly, modification was made and can be referred in lines 88-90, 94-95. 2. Lines 195 - 200 - please expand this. Zonal location and type of pharmacy were associated with dispensing, but it is not clear what that means. What is a zonal location? Which ones had which effect? What kind of pharmacy was associated with dispensing? Response: Accepted. Eritrea is divided administratively into six zones (regions). And, zonal (regional) location mentioned in the manuscript stands for this administrative classification.As per the study’s result, the place where a drug retail outlet is located and a drug retail outlet being a private pharmacy, private drug shop, or governmental pharmacy were found to affect the dispensing behavior.The magnitude of the influence is further explained in lines 207-213. 3. Lines 223-238 - This entire paragraph is confusing. It seems to say that the likelihood of dispensing without a prescription is lower in some areas and higher in others. Referring to this as prevalence is confusing. Response: Comment well taken. We have edited the paragraph to make it more pellucid. 4. The paper needs a Limitations section. What should the reader be aware of when determining the validity and accuracy of the paper? Response: Accepted We have added one limitation as a sub section of the discussion. 5. References - Reference 13 has no journal listed. References 16 and 20 have extraneous information in the citation. Response: Accepted We have removed the extraneous information from references 16 and 20. But for reference 13, “Expert review of anti-infective therapy” is the name of the journal cited. 6. You correctly point out that uncontrolled access to antibiotics has a number of significant concerns including increases bacterial resistance. But it is also important to consider that strictly enforcing restrictions on drug sales in many parts of the Global South can have the unintended consequence of preventing patients who cannot afford a clinic or doctor from receiving any treatment at all. What policy recommendations do you make as a result of your study? Response: Accepted We understand the concern that could emerge by enforcing strict restrictions on drug retails. But, the case is different in Eritrea. The fee for health services is nominal, and it is also free for those who claim who cannot afford at all. Moreover, sometimes it is also more expensive for services provided in drug retail outlets than in health facilities. Considering this fact in our country, we don’t believe the recommended restrictions could have considerable effect on preventing indigent patients from receiving treatments. We have also recommended a further research to unveil the reasons that motivate the sales of antibiotics and patients seeking for antibiotics from drug retails even when they can have an access to health facilities. Reviewer’s comments 1.Around line 122- I think it’s important that you note that both of these disease states likely require laboratory aided diagnosis to confirm if it is a bacterial infection; make that connection so that the reader (especially if they are not a healthcare professional) understands that antibiotics may not be warranted in all patients with these symptoms. This is key as otherwise the reader may not connect the irrational use piece and would need to understand why the patient would need to go to the doctor for a workup vs just receiving the antibiotic. Response: Accepted Thank you for the interesting comment. To make it clear, we have added in the paragraph that both the disease states require laboratory aided diagnosis to confirm the etiologic agent. 2. Figure 1 - will the lines 131-136 go with the figure? Otherwise it is confusing. Response: Accepted Yes, they go with the figure. The title of the figure is “Figure 1: Data collection process. ”And, the legend of the figure is“Figure 1 Legend: key indicators* included name tag, professional license, appearance of the dispenser key indicators of dispensing practices ** included name of antibiotics dispensed (if any),demand level, reasons for not dispensing, and alternative medications offered (if any) NMFA: National Medicines and Food Administration.” 3. Line 142: I believe you mean it was a “pilot test” of the data collection process/questionnaire vs a “pre-test” which would imply that there is a post-test Response: Accepted A pre-test study for the questionnaire was done to check the comprehensibility the data collection tool. As we conducted it in only 4 drug retail outlets, we cannot dare to call a pilot study. Since no modifications were made, it was not necessary to conduct a post-test. But, we have edited the sentence to indicate that the pre-test was done for the questionnaire, not for the data collection process. 4) Line 192 and again lower, I’m confused about the term “administrative restrictions” operationalize this term in the paper Response: Accepted As we have added in the paragraph, the term “administrative restrictions”indicates for the rules and regulations set by individual drug retail outlets for their own practices. 5) I would like to see the sample size for each of the types of pharmacies and pharmacy locations. Consider adding n= to each on Table 3 Response: Accepted We have added the number of samples in the specified table 3. 6) Line 224 – your study doesn’t prove if there is “excessive consumption” as your student doesn’t specifically measure if those with the symptoms may have an infection. I would add the word “potential” excessive consumption – or something similar Response: Accepted We have eliminated the term “excessive consumption” from the sentence. 7) Line 239 – this is an assumption, change “can” to “may” or “might” Response: Modification is done accordingly. 8) Line 269 – while you mention Cipro is on the WHO watch group, I think it is important to address the potential issues with TB and prescribing a drug from this class without consideration of TB. Response: The comment is addressed well. (Refer lines 264-267) 9) As PLOS does not have a copyeditor, I would have someone who is skilled and is not one of the authors (for fresh eyes), give your paper a final proofreading. There are some issues with spacing - sometimes too many, sometimes not enough. On occasion there are dropped articles ("a"); that said, the articles could be a matter of British vs. American English. There are also some capitalization inconsistencies in table 1, and in your paper pharmacy should always be lowercase unless part of the name of a location. Eliminate the conjunction in line 140. Overall, this is a well done study and well written paper. Response: Thank you for the comments. The manuscript has been proofread by a skilled person and believed to be improved. We believe that the comments are addressed and communicated thoroughly. Additionally, we would like to inform you that the line numbers given can only match with the cleaned revised manuscript. We are looking forward to receiving your decision at your earliest convenience. Kind regards, Authors: Merhawi Bahta, Sirak Tesfamariam, Dawit G. Weldemariam, Hermella Yemane, Eyasu H. Tesfamariam, Tesfamariam Alem, and Mulugeta Russom 7 Jan 2020 Dispensing of antibiotics without prescription and associated factors in drug retail outlets of Eritrea: a simulated client method PONE-D-19-28324R1 Dear Dr. Dawit G. Weldemariam We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, John Rovers, PharmD, MIPH Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: 14 Jan 2020 PONE-D-19-28324R1 Dispensing of antibiotics without prescription and associated factors in drug retail outlets of Eritrea: a simulated client method Dear Dr. Weldemariam: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. John Rovers Academic Editor PLOS ONE
  21 in total

1.  Small pharmacies are more likely to dispense antibiotics without a medical prescription than large pharmacies in Catalonia, Spain.

Authors:  C Llor; Dl Monnet; Jm Cots
Journal:  Euro Surveill       Date:  2010-08-12

2.  Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study.

Authors:  Larissa Grigoryan; Johannes G M Burgerhof; John E Degener; Reginald Deschepper; Cecilia Stålsby Lundborg; Dominique L Monnet; Elizabeth A Scicluna; Joan Birkin; Flora M Haaijer-Ruskamp
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-11       Impact factor: 2.890

3.  Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany.

Authors:  K Berger; C Eickhoff; M Schulz
Journal:  J Clin Pharm Ther       Date:  2005-02       Impact factor: 2.512

4.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

5.  A European study on the relationship between antimicrobial use and antimicrobial resistance.

Authors:  Stef L A M Bronzwaer; Otto Cars; Udo Buchholz; Sigvard Mölstad; Wim Goettsch; Irene K Veldhuijzen; Jacob L Kool; Marc J W Sprenger; John E Degener
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

6.  Attitudes of community pharmacists to antibiotic dispensing and microbial resistance: a qualitative study in Portugal.

Authors:  Fátima Roque; Sara Soares; Luiza Breitenfeld; Ana López-Durán; Adolfo Figueiras; Maria Teresa Herdeiro
Journal:  Int J Clin Pharm       Date:  2013-02-09

7.  Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications.

Authors:  Vanda Marković-Peković; Nataša Grubiša; Johanita Burger; Ljubica Bojanić; Brian Godman
Journal:  J Res Pharm Pract       Date:  2017 Apr-Jun

8.  Evaluation of antibiotic dispensing practice in community pharmacies in Jordan: A cross sectional study.

Authors:  Randa N Haddadin; Mervat Alsous; Mayyada Wazaify; Linda Tahaineh
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

9.  Prevalence of self-medication with antibiotics and associated factors in the community of Asmara, Eritrea: a descriptive cross sectional survey.

Authors:  Yonatan Ateshim; Batseba Bereket; Feruz Major; Youel Emun; Biruck Woldai; Ismail Pasha; Eyasu Habte; Mulugeta Russom
Journal:  BMC Public Health       Date:  2019-06-10       Impact factor: 3.295

10.  Over the Counter Sale of Antibiotics at Drug Stores Found in Mizan-Aman Town, Southwest Ethiopia: A Cross-Sectional Simulated Client Visit Study.

Authors:  Getahun Damisie; Solomon Hambisa; Mohammed Yimam
Journal:  J Pharm (Cairo)       Date:  2019-04-07
View more
  8 in total

1.  Extent of and Factors Associated with Self-Medication among Clients Visiting Community Pharmacies in the Era of COVID-19: Does It Relieve the Possible Impact of the Pandemic on the Health-Care System?

Authors:  Aklilu Tekeba; Yohanes Ayele; Belay Negash; Tigist Gashaw
Journal:  Risk Manag Healthc Policy       Date:  2021-12-13

Review 2.  Non-prescription dispensing of antibiotic agents among community drug retail outlets in Sub-Saharan African countries: a systematic review and meta-analysis.

Authors:  Sewunet Admasu Belachew; Lisa Hall; Linda A Selvey
Journal:  Antimicrob Resist Infect Control       Date:  2021-01-14       Impact factor: 4.887

3.  Medication selection for the treatment of acute infective diarrhea in Thai pharmacies: a qualitative study.

Authors:  Nattawut Leelakanok; Arpa Petchsomrit; Janthima Methaneethorn; Suphannika Prateepjarassaeng Pornwattanakavee
Journal:  Transl Clin Pharmacol       Date:  2021-12-16

4.  Knowledge, attitude and practice of antibiotics and their determinants in Eritrea: an urban population-based survey.

Authors:  Mulugeta Russom; Merhawi Bahta; Merhawi Debesai; Iyassu Bahta; Abrahalei Kessete; Aziza Afendi; Yodit Fitsum; Josephine Nambozi; Solyana N Kidane; Eyasu H Tesfamariam
Journal:  BMJ Open       Date:  2021-09-24       Impact factor: 3.006

5.  Assessment of without prescription antibiotic dispensing at community pharmacies in Hazara Division, Pakistan: A simulated client's study.

Authors:  Tawseef Ahmad; Faiz Ullah Khan; Sayyad Ali; Asad Ur Rahman; Shujaat Ali Khan
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

6.  Demand of COVID-19 medicines without prescription among community pharmacies in Jodhpur, India: Findings and implications.

Authors:  Siddhartha Dutta; Rimple J Kaur; Pankaj Bhardwaj; Sneha Ambwani; Brian Godman; Pallavi A Jha; Sanchi Sukhija; Suman S Venkatesh; Halyna Lugova; Salequl Islam; Jaykaran Charan; Mainul Haque
Journal:  J Family Med Prim Care       Date:  2022-02-16

Review 7.  Impact of Anthropogenic Activities on the Dissemination of ARGs in the Environment-A Review.

Authors:  Małgorzata Czatzkowska; Izabela Wolak; Monika Harnisz; Ewa Korzeniewska
Journal:  Int J Environ Res Public Health       Date:  2022-10-07       Impact factor: 4.614

Review 8.  Antibiotic Dispensation without a Prescription Worldwide: A Systematic Review.

Authors:  Ana Daniela Batista; Daniela A Rodrigues; Adolfo Figueiras; Maruxa Zapata-Cachafeiro; Fátima Roque; Maria Teresa Herdeiro
Journal:  Antibiotics (Basel)       Date:  2020-11-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.